Total Payments
$7,744
2024 Payments
$361.54
Companies
34
Transactions
380
Medicare Patients
6,527
Medicare Billing
$390,648
Payment Breakdown by Category
Food & Beverage$6,988 (90.2%)
Travel$752.34 (9.7%)
Education$4.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,988 | 375 | 90.2% |
| Travel and Lodging | $752.34 | 4 | 9.7% |
| Education | $4.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,417 | 91 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,152 | 16 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $1,062 | 50 | $0 (2023) |
| Amgen Inc. | $643.63 | 32 | $0 (2024) |
| PFIZER INC. | $531.56 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $434.19 | 29 | $0 (2024) |
| Boston Scientific Corporation | $333.12 | 17 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $295.91 | 17 | $0 (2024) |
| Abbott Laboratories | $240.21 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $198.46 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.54 | 20 | Novartis Pharmaceuticals Corporation ($167.69) |
| 2023 | $785.18 | 43 | Novartis Pharmaceuticals Corporation ($363.93) |
| 2022 | $302.16 | 15 | Novartis Pharmaceuticals Corporation ($95.60) |
| 2021 | $710.51 | 37 | Novartis Pharmaceuticals Corporation ($239.99) |
| 2020 | $429.31 | 23 | Janssen Pharmaceuticals, Inc ($205.87) |
| 2019 | $1,280 | 71 | Janssen Pharmaceuticals, Inc ($242.52) |
| 2018 | $1,291 | 73 | Janssen Pharmaceuticals, Inc ($253.95) |
| 2017 | $2,585 | 98 | Medtronic Vascular, Inc. ($1,138) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $48.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Cardiovascular | ||||||
| 02/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology | ||||||
| 02/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/15/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Heart Failure | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,809 | 2,778 | $322,905 | $97,603 |
| 2022 | 15 | 1,520 | 2,362 | $289,474 | $88,131 |
| 2021 | 18 | 1,628 | 2,546 | $309,663 | $104,086 |
| 2020 | 19 | 1,570 | 2,308 | $304,099 | $100,828 |
Total Patients
6,527
Total Services
9,994
Medicare Billing
$390,648
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 351 | $96,525 | $30,811 | 31.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 130 | $27,950 | $12,687 | 45.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 145 | $21,750 | $9,408 | 43.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 83 | $23,655 | $8,754 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 53 | $21,995 | $7,537 | 34.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 736 | 1,148 | $46,000 | $7,241 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 87 | 90 | $13,050 | $4,530 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 197 | 339 | $18,645 | $3,522 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,560 | $2,448 | 32.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 31 | $5,580 | $1,992 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $6,540 | $1,896 | 29.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 41 | 87 | $7,830 | $1,700 | 21.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 33 | 70 | $11,200 | $1,674 | 14.9% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 11 | 16 | $2,880 | $881.53 | 30.6% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 12 | 12 | $2,040 | $609.51 | 29.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 26 | 27 | $1,485 | $543.78 | 36.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 26 | 26 | $1,690 | $422.98 | 25.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 26 | 26 | $1,300 | $282.75 | 21.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 18 | $1,080 | $248.17 | 23.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 15 | 16 | $1,920 | $157.60 | 8.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 25 | 26 | $910.00 | $151.06 | 16.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 42 | 44 | $1,320 | $106.99 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 368 | $99,779 | $33,419 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 124 | $27,254 | $10,321 | 37.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 58 | 62 | $25,985 | $9,946 | 38.3% |
About Dr. Marino Leonardi, MD
Dr. Marino Leonardi, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Norristown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467461707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marino Leonardi, MD has received a total of $7,744 in payments from pharmaceutical and medical device companies, with $361.54 received in 2024. These payments were reported across 380 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,988).
As a Medicare-enrolled provider, Leonardi has provided services to 6,527 Medicare beneficiaries, totaling 9,994 services with total Medicare billing of $390,648. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Norristown, PA
- Active Since 08/05/2006
- Last Updated 01/24/2017
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1467461707
Products in Payments
- ENTRESTO (Drug) $1,342
- XARELTO (Drug) $1,130
- Micra (Device) $1,003
- ELIQUIS (Drug) $656.77
- Corlanor (Drug) $468.31
- LifeVest (Device) $295.91
- Repatha (Biological) $171.32
- PRADAXA (Drug) $169.61
- Vascepa (Drug) $160.95
- CHANTIX (Drug) $157.95
- WATCHMAN (Device) $139.91
- CardioMEMS HF System (Device) $122.84
- PRALUENT (Drug) $110.95
- PRALUENT ALIROCUMAB INJECTION (Biological) $105.77
- VYNDAQEL (Drug) $90.38
- WATCHMAN Access System (Device) $85.24
- SelectSecure (Device) $84.13
- LAA035, LAA040, LAA045, LAA050 (Device) $81.29
- LEQVIO (Drug) $74.45
- Pacemakers (Device) $71.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.